NasdaqCM - Nasdaq Real Time Price USD

Revelation Biosciences, Inc. (REVB)

3.1700
+0.0800
+(2.59%)
As of 2:41:30 PM EDT. Market Open.
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
6,622.0490
12,212.6090
5,503.4150
2,042.2120
Total Liabilities Net Minority Interest
1,913.6670
5,564.8940
4,450.9620
2,141.6820
Total Equity Gross Minority Interest
4,708.3820
6,647.7150
1,052.4530
-99.4700
Total Capitalization
4,708.3820
6,647.7150
1,052.4530
-99.4700
Preferred Stock Equity
--
--
--
7,481.9270
Common Stock Equity
4,708.3820
6,647.7150
1,052.4530
-99.4700
Capital Lease Obligations
--
--
0
16.7520
Net Tangible Assets
4,708.3820
6,647.7150
1,052.4530
-99.4700
Working Capital
4,652.0500
6,582.6310
962.3200
-229.6110
Invested Capital
4,708.3820
6,647.7150
1,052.4530
-99.4700
Tangible Book Value
4,708.3820
6,647.7150
1,052.4530
-99.4700
Total Debt
--
--
0
16.7520
Share Issued
522.2800
16.5330
1.4220
0.7700
Ordinary Shares Number
522.2800
16.5330
1.4220
0.7700
12/31/2021 - 11/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers